Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment | MicrobiomeTrials← Back to trialsNCT06279013
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-10-14Est. Completion: 2028-06-01
Enrollment target: 486 participants Locations- Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
- CARTI Cancer Center, Little Rock, Arkansas, United States
- Phoebe Putney Memorial Hospital, Albany, Georgia, United States
- Augusta Oncology Associates PC-D'Antignac, Augusta, Georgia, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States
- Queen's Medical Center, Honolulu, Hawaii, United States
- Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States
- The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, United States
- John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
- Carle at The Riverfront, Danville, Illinois, United States
- Carle Physician Group-Effingham, Effingham, Illinois, United States
- Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
- Carle Cancer Center, Urbana, Illinois, United States
- Central Care Cancer Center - Garden City, Garden City, Kansas, United States
- University Medical Center New Orleans, New Orleans, Louisiana, United States
Other microbiome trials you might be interested in
Accelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative NeoplasmEssential ThrombocythemiaMyelodysplastic/Myeloproliferative NeoplasmMyeloproliferative Neoplasm, Not Otherwise SpecifiedPolycythemia VeraPrimary MyelofibrosisSecondary Myelofibrosis
This phase II trial compares the effect of ASTX727 in combination with iadademstat to ASTX727 alone in treating patients…
Irvine, United StatesEst. completion Dec 31, 2027
Lake Regional Hospital, Osage Beach, Missouri, United StatesUniversity of New Mexico Cancer Center, Albuquerque, New Mexico, United StatesAnMed Health Cancer Center, Anderson, South Carolina, United StatesMedical University of South Carolina, Charleston, South Carolina, United StatesPrisma Health Cancer Institute - Butternut, Greenville, South Carolina, United StatesPrisma Health Cancer Institute - Faris, Greenville, South Carolina, United StatesPrisma Health Greenville Memorial Hospital, Greenville, South Carolina, United StatesPrisma Health Cancer Institute - Eastside, Greenville, South Carolina, United StatesAspirus Cancer Care-Antigo-Volm Cancer Center, Antigo, Wisconsin, United StatesAspirus Medford Hospital, Medford, Wisconsin, United StatesAspirus Cancer Care-Rhinelander-James Beck Cancer Center, Rhinelander, Wisconsin, United StatesAspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United StatesAspirus Cancer Care-Wausau, Wausau, Wisconsin, United StatesAspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United StatesPuerto Rico Hematology Oncology Group, Bayamón, Puerto RicoDoctors Cancer Center, Manati, Puerto RicoCentro Comprensivo de Cancer de UPR, San Juan, Puerto RicoPROncology, San Juan, Puerto RicoRecruiting
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin LymphomaNon-Hodgkin LymphomaMyelodysplastic SyndromeMyeloproliferative SyndromeRhabdomyosarcomaEwing SarcomaPrimitive Neuroectodermal TumorOsteosarcomaNeuroblastoma
This phase I trial studies the safety of transplantation with a haploidentical donor peripheral blood stem cell graft de…
Madison, United StatesEst. completion Dec 2026
Multiple Myeloma, Newly Diagnosed
This is a prospective, single-arm, phase II study to evaluate the efficacy and safety of autologous stem cell transplant…
Tianjin, ChinaEst. completion Aug 1, 2027